NewsRoom Articles - Page 367 of 1255

TuesdayFeb 09, 2021 9:58 am

Chinese Social Media Powerhouse Momo Inc. (NASDAQ: MOMO) Renews its Drive Amid Pandemic-era Adversity

Chinese mobile-based social and entertainment platform operator Momo is regrouping and revisiting its successes after suffering a pair of adverse conditions resulting from government concerns and pandemic problems Momo has developed a prominent reputation as “China’s Tinder” through its Tantan dating service platform and its Momo streaming video app The company saw some of its top leadership positions change last year in response to declines in revenue and stock value The company has generated some encouraging reports since the start of the year with a brief surge in stock value and forecasts that anticipate it will “retain growth momentum on…

MondayFeb 08, 2021 2:34 pm

United Medical Equipment Business Solutions Network Inc. Offers Rapid COVID-19 Test Designed to Identify Infection

FDA has authorized 225-plus diagnostic tests for COVID-19 since pandemic began CareStart(TM) COVID-19 antigen test received FDA authorization in July 2020 UME carries CareStart antigen kit, a powerful component of COVID-19 screening process Since the beginning of the COVID-19 pandemic, the U.S. Food and Drug Administration (“FDA”) has authorized more than 225 diagnostic tests for COVID-19 in an effort to provide growing resources to combat the disease. United Medical Equipment Business Solutions Network (“UME”), a company committed to offering a comprehensive line set of COVID-19 products, recently added one of those tests — the CareStart(TM) COVID-19 rapid antigen kit —…

MondayFeb 08, 2021 2:27 pm

RYAH Group Inc. Well Positioned as Data Continues to Shape Future of Medical Research

Recent article finds that data remains one of main drivers of medical research in 2021. New technologies employing AI powered by big data provide new solutions for tackling health problems, expand possibilities of clinical research RYAH combines power of devices combined with data to impact future of medical research to advance treatment of various medical conditions A recent Becker’s Hospital Review article cites 10 emerging trends in health IT that will shape this field in 2021, reporting that big data management is becoming a need as the use of artificial intelligence (“AI”) and machine learning in healthcare continues to blossom…

MondayFeb 08, 2021 2:14 pm

SRAX Inc.’s (NASDAQ: SRAX) Sequire Provides Public Companies with Actionable Insights on Investor Activity While Severe Volatility Grips Markets

Investor uncertainty rising as volatility continues to negatively affect stock market SRAX’s Sequire investor analytics platform provides actionable insights into investor behaviors for public companies Sequire has grown to 3 million+ active users across 90 public companies since 2019 Q3 2020 performance includes $6.7 million in bookings, 37% increase in subscriptions, 161% year-over-year and 124% quarter-over-quarter revenue growth Despite record levels of unemployment, threats of extreme inflation and runaway government spending, the stock market appears to have decoupled from the greater economy with record highs amid unprecedented levels of volatility (https://nnw.fm/aFLd5). As uncertainty among investors continues to grow, many public companies…

MondayFeb 08, 2021 1:53 pm

Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is ‘One to Watch’

Excellon’s portfolio currently includes active production at the Platosa Mine, with four additional assets in the development or exploration stages Excellon saw significant increases in production of lead, zinc and silver at the Platosa Mine from Q4 2019 to Q4 2020 The Company is advancing a precious metals growth pipeline that includes: Platosa, Mexico’s highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho with strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany with 750 years of mining history and…

MondayFeb 08, 2021 12:34 pm

2021 Strategic Plan Showcases API Potential of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp. is a life sciences technology accelerator involved in the development of new pharmaceuticals, diagnostic products and psychedelic investments XPhyto is preparing a series of clinical pilot studies for four drug candidates this year that could help in treating Parkinson’s disease, epilepsy, anorexia and other neurological conditions The company has developed a rapid and highly portable PCR test kit it expects to commercialize this year to provide point-of-care diagnostics, designed for satellite labs to quickly screen for the COVID-19 virus Wholly owned subsidiary Vektor, a German drug maker and researcher, plans to build a new commercial drug manufacturing…

MondayFeb 08, 2021 12:12 pm

Predictive Oncology Inc. (NASDAQ: POAI) Stands to Benefit from Explosive Growth of Precision Medicine

Precision medicine in oncology allows for clinicians to develop personalized cancer treatment plans using individual characteristics of each patient Doctors use insights drawn from laboratory-grown cancer cells, patients’ DNA to individualize cancer treatment Predictive Oncology has been forerunner in its field, both through Helomics division’s smart tumor profiling platform as well as TumorGenesis subsidiary, which creates the tools used in ovarian cancer research TumorGenesis has begun to commercialize intellectual property, having received first order for unique ovarian cancer cell culture media in June 2020 In the summer of 2018, 49-year-old Star Dolbier arrived at the University of Maryland Greenebaum Cancer…

FridayFeb 05, 2021 2:22 pm

Hollywall Entertainment Inc. (HWAL) Begins Roll-out of New HW Vision Media and Telecommunications Brand

Hollywall Entertainment Inc. is a technology and broadcasting company with a deep reserve of entertainment media content that it is distributing through its network in the U.S. East and South regions Hollywall began rolling out its new, wholly owned brand HW Vision at the end of January to provide cellular equipment and services, streaming media content, live television and on-demand programming HWAL’s mission is to use its growing telecommunications prowess as a socio-economic equalizer for rural and underserved minority communities The company’s telecommunications networks will also deliver capabilities for telemedicine and tele-education — services that have become valuable during the…

FridayFeb 05, 2021 1:57 pm

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Is ‘One to Watch’

TAAT Lifestyle & Wellness is focused on serving the current smokers’ market, offering its target audience the opportunity to keep the smoking experience that they enjoy with no nicotine and no tobacco The company’s proprietary product, TAAT Beyond Tobacco, undergoes a patent-pending refinement process The product was successfully launched in Ohio during Q4 2020, with nearly one-third of the visitors to the TryTAAT webpage requesting their samples by mail TAAT Lifestyle & Wellness management is highly experienced in the tobacco industry, including roles with larger businesses like Philip Morris International The global tobacco market was estimated at $849 billion in…

FridayFeb 05, 2021 1:43 pm

Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Proprietary System Could Help Reduce Bladder Cancer Recurrence

The current standard for bladder cancer visualization, white light, is over three decades old and used in 95% of the bladder cancer surgeries The recurrence rate of bladder cancer is more than 50% due to the inability to see clear margins in the white light surgical standard for visualization Imagin Medical Inc.’s proprietary i/Blue(TM) System changes the way that surgeons visualize bladder cancer with side-by-side imaging of white and blue light pictures on one screen Blue light procedures are capable of reducing recurrence rates by 12-43% depending on the type, stage, and grade of bladder cancer The global bladder cancer…

Financial news and publishing for public and private companies

Contact us: 212.418.1217